Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Cross-sectional analysis of the reliability and engagement metrics of YouTube videos on semaglutide for weight loss
Medicine;105(23):e49173
The efficacyand safety of once weekly injectable semaglutide (Ozempic) among patients with Type 2 diabete sintertiary care hospital: A Retrospective Study
JPMA. The Journal of the Pakistan Medical Association;76(5):709-712
Semaglutide: Real World Results, Realistic Recommendations
JPMA. The Journal of the Pakistan Medical Association;76(5):644-645
Brachial Plexopathy Following Rapid Weight Loss from Tirzepatide: A Case Report
Pain medicine case reports;10(3):233-236
Use of second-generation incretin analogs (GLP-1 and GIP receptor agonists) in type 1 diabetes and latent autoimmune diabetes in adults: A systematic review
Journal of the American Association of Nurse Practitioners, 2026
Semaglutide-induced loss of skeletal muscle mass is blunted by co-administration of ketone esters
JCI insight, 2026
TOGETHER-PsA and the Case for Precision Phenotyping in Psoriatic Arthritis Commentary on: “Ixekizumab with Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults with Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial”
Arthritis & rheumatology (Hoboken, N.J.), 2026
Semaglutide showed limited improvements in patients with Alzheimer’s disease: Revisiting the evoke and evoke + clinical trials
Journal of Alzheimer's disease : JAD, 2026;:13872877261458402
Changes of Transcriptomic Activity in Rat Brain Cells under the Influence of Synthetic Adrenocorticotropic Hormone-Like Peptides
Biochemistry. Biokhimiia;89(9):1643-1656
Early Generic Semaglutide in Canada-Implications for US Patients and Policy
JAMA internal medicine, 2026
Differential impact of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss in the type 2 diabetic and non-diabetic populations
Surgical endoscopy, 2026
A cross-species atlas of the dorsal vagal complex reveals neural mediators of the effects of cagrilintide on energy balance
Nature metabolism, 2026
Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial
Nature medicine, 2026
Optic Ischaemic Neuropathy in Incretin-Based Therapy: A Comparative Analysis of Real-World Safety Data
Diabetes, obesity & metabolism, 2026
Risk of Age-Related Ocular Diseases in Non-Diabetic Adults With Obesity Using Glucagon-Like Peptide 1 Receptor Agonists
Diabetes, obesity & metabolism, 2026
Endoscopic Sleeve Gastroplasty Versus Oral Semaglutide for Obesity: A Real-World Comparative Cohort Study
Endoscopy, 2026
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with type 2 diabetes (SOLSTICE): a multicentre, phase 2b, randomised, placebo-controlled trial
Lancet (London, England), 2026
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer’s Disease
Acta naturae;17(4):110-120
Glycyl-l-histidyl-l-lysine prevents copper- and zinc-induced protein aggregation and central nervous system cell death in vitro
Metallomics : integrated biometal science;16(5)
Dose-Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026